GlaxoSmithKline - Wellbutrin XL - Ownership and Business Overview

Life ScienceCompany

GlaxoSmithKline - Wellbutrin XL Ownership

Who owns GlaxoSmithKline - Wellbutrin XL?

GlaxoSmithKline - Wellbutrin XL is owned by Biovail. It was acquired on May 6, 2009.

GlaxoSmithKline - Wellbutrin XL Business Overview

Where is GlaxoSmithKline - Wellbutrin XL headquartered?

GlaxoSmithKline - Wellbutrin XL is headquartered in United States.

What sector is GlaxoSmithKline - Wellbutrin XL in?

GlaxoSmithKline - Wellbutrin XL is a life science company.

When was GlaxoSmithKline - Wellbutrin XL founded?

GlaxoSmithKline - Wellbutrin XL was founded in 2003.

Life Science M&A Summary in 2009

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009. The largest life science acquisition in 2009 was Wyeth - which was acquired by Pfizer for $68.0B.

Join Mergr to view all 111 acquisitions of life science companies in 2009, including 13 acquisitions by private equity firms, and 98 by strategics.

GlaxoSmithKline plc - Wellbutrin XL


United States,

GlaxoSmithKline plc - Wellbutrin XL which is indicated for the treatment of major depressive disorder and seasonal affective disorder, was developed and is manufactured by Biovail and has been distributed by GSK in the United States since September 2003.


 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for GlaxoSmithKline - Wellbutrin XL

Life Science Companies , United States Companies